Sun Pharma Advanced Research Company Limited

₹197.03As of Sun 8 Nov 2026, 12:00 UTC
NSE:SPARCHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR (5.59%)
Div yield —
ROE 298.10%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.67
PE TTM 3.914
TSR TTM 45.74%
Mkt cap ₹63.94B
ROIC 135.01%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹213
8.35%
293.59%
Hold 2|12|7|4|3
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
1.91
2.00
2.19
2.35
20.49%
20.49%
19.99%
27.12%
Revenue₹B
3.679
3.840
4.008
4.101
1.89%
9.00%
9.39%
8.66%
Peers (US$669.6M)
Cap (US$)
PE
684.0M
48.73x
676.6M
20.29x
623.6M
38.02x
Capital
TTM
5Y
10Y
Leveragex
0.159
(0.133)
(0.135)
EBIT/Intx
0.833
0.263
0.269
Own earn%
131.29
(133.89)
(109.38)
Sh yield%
31.05
57.16
56.65
Owners
Insiders/Inst%
12.15
45.70
Short interest%
5.59
SBC / revenue%
5.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
11–18
$1 testx
−1.3
Incr. ROIC%
7